$BAC·3

Bluejay Diagnostics, Inc. · Jul 10, 2:28 PM ET

BANK OF AMERICA CORP /DE/ 3

3 · Bluejay Diagnostics, Inc. · Filed Jul 10, 2026

Insider Transaction Report

Form 3
Period: 2026-07-07
Holdings
  • Common Stock

    [F1][F2][F3]
    (indirect: See Footnotes)
    8
Footnotes (3)
  • [F1]The 8 common stock shares ("Shares") reported as acquired in Table I represent Shares of BLUEJAY DIAGNOSTICS, INC.("the Issuer") beneficially owned by Bank of America N.A. ("BANA"), and BofA Securities, Inc. ("BOFAS"). BANA and BOFAS are wholly owned subsidiaries of Bank of America Corporation ("Bank of America"). The Reporting Owners may be deemed to have temporarily held voting and dispositive power over additional Shares as a result of short-term stock borrowings.
  • [F2]This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I ("the Securities") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS.
  • [F3]Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

Documents

2 files
  • 3
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT

  • EX-99.1

    JOINT FILING AGREEMENT